The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1H-indol-3-yl)-1-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine ID: ALA4779893
PubChem CID: 162662902
Max Phase: Preclinical
Molecular Formula: C24H18N6
Molecular Weight: 390.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1c(-c1c[nH]c3ccccc13)nn2Cc1cccc2ccccc12
Standard InChI: InChI=1S/C24H18N6/c25-23-21-22(19-12-26-20-11-4-3-10-18(19)20)29-30(24(21)28-14-27-23)13-16-8-5-7-15-6-1-2-9-17(15)16/h1-12,14,26H,13H2,(H2,25,27,28)
Standard InChI Key: WAZPAAIYYPNPQP-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 35 0 0 0 0 0 0 0 0999 V2000
15.4812 -27.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1789 -27.2355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3396 -24.7588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1050 -25.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6714 -26.1460 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1360 -24.5677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1534 -26.4161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8064 -25.9133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5286 -25.1367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7040 -25.1621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4746 -25.9544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3665 -23.7795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8982 -24.4037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1076 -23.0914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5254 -23.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8355 -23.4670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7061 -24.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3413 -24.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1061 -24.4970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2322 -23.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5959 -23.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7610 -27.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0638 -27.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0864 -28.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5061 -28.4790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8114 -28.9080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8364 -29.7224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5556 -30.1086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2509 -29.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2224 -28.8618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
4 5 1 0
5 11 2 0
10 6 2 0
6 3 1 0
10 11 1 0
8 9 2 0
7 8 1 0
9 10 1 0
11 7 1 0
6 12 1 0
7 2 1 0
9 13 1 0
13 17 1 0
16 14 1 0
14 15 1 0
15 13 2 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 1 1 0
1 22 2 0
22 23 1 0
23 24 2 0
24 26 1 0
25 1 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 25 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.45Molecular Weight (Monoisotopic): 390.1593AlogP: 4.76#Rotatable Bonds: 3Polar Surface Area: 85.41Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.65CX LogP: 4.48CX LogD: 4.48Aromatic Rings: 6Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -0.78
References 1. Gilles P,Kashyap RS,Freitas MJ,Ceusters S,Van Asch K,Janssens A,De Jonghe S,Persoons L,Cobbaut M,Daelemans D,Van Lint J,Voet ARD,De Borggraeve WM. (2020) Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors., 205 [PMID:32835918 ] [10.1016/j.ejmech.2020.112638 ]